Cancer drug blow hits Astra.PHARMACEUTICALS giant Astra Zeneca saw its share price fall sharply yesterday after it emerged that a key drug in its portfolio did not boost the survival chances of some patients. Astra Zeneca, based in Alderley Edge, Cheshire Edge is a small village and civil parish in Chester District, Cheshire, England. The parish includes Edge Hall and Edge Green. • • , said the trial of 1, 700 lung cancer lung cancer, cancer that originates in the tissues of the lungs. Lung cancer is the leading cause of cancer death in the United States in both men and women. Like other cancers, lung cancer occurs after repeated insults to the genetic material of the cell. sufferers showed the treatment, Iressa, which is not available in the UK, shrank tumours but not to an extent that it significantly prolonged life. Nearly pounds 3bn was knocked off shares after the announcement, which came just a month after Astra Zeneca suffered a setback on anti-cholesterol drug Crestor. Around 210, 000 patients in more than 30 countries including the US, Japan, Canada, Australia and Switzerland have already been treated with Iressa while it awaits full approval. Chief executive Sir Tom McKillop Sir Thomas Fulton Wilson McKillop, born March 19, 1943, is a chemist and pharmaceutical company CEO. McKillop was born in Dreghorn, a small village near the town or Irvine in Ayrshire and educated at Irvine Royal Academy and then Glasgow University, where he took a BSc Hons , who is determined to restore confidence in the company, yesterday appointed a new director to bolster the development arm. He said: ``These recent disappointments, set in a more hostile environment towards pharmaceutical stocks, have resulted in a substantial loss of value. '' |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion